Long-term extension study made to evaluate the long-term efficacy and safety of migalastat HCl.

FDA acceptance to lift the current hold on the AT2220 program within its development plan. Diseases of Neurodegeneration Amicus is usually investigating the potential use of pharmacological chaperones for the treating genetically described sub-populations of individuals with Parkinson’s disease and Alzheimer’s disease. Fox Base . Additionally, Amicus proceeds to progress its preclinical program analyzing a pharmacological chaperone strategy for the treatment of Alzheimer’s disease.4M grant to create nanoparticle system to shore up arterial walls A UT Arlington bioengineer has received a four-calendar year, $1.4 million National Institutes of Health grant to make a nanoparticle system to shore up arterial walls following angioplasty and stenting methods to take care of coronary arterial disease.